Selby Nicholas M, McIntyre Christopher W
Department of Renal Medicine, Derby City Hospital, Uttoxeter Road, Derby, DE22 3NE, UK.
Nephrol Dial Transplant. 2006 Jul;21(7):1883-98. doi: 10.1093/ndt/gfl126. Epub 2006 Apr 6.
Intradialytic hypotension (IDH) is a frequent complication of haemodialysis. Reducing the temperature of the dialysis fluid is a simple therapeutic strategy but is relatively underused. This may be due to concerns regarding its effects on symptoms and dialysis adequacy. We performed a systematic review of the literature to examine the effects of cool dialysis on intradialytic blood pressure, and to assess its safety in terms of thermal symptoms and small solute clearance.
We searched the Cochrane Central Register of Controlled Trials, Medline, Embase, Cumulative Index to Nursing and Allied Health Literature, databases of ongoing trials, the contents of four major renal journals as well as hand-searching reference lists. We included all prospective randomized studies that compared any technique of reducing dialysate temperature with standard bicarbonate dialysis. These techniques included an empirical, fixed reduction of dialysate temperature or use of a biofeedback temperature-control device (BTM) to deliver isothermic dialysis or programmed patient cooling.
A total of 22 studies comprising 408 patients were included (16 studies examined a fixed empirical temperature reduction and six examined BTM). All studies were of crossover design and relatively short duration. IDH occurred 7.1 (95% CI, 5.3-8.9) times less frequently with cool dialysis (both fixed reduction and BTM). Post-dialysis mean arterial pressure was higher with cool-temperature dialysis by 11.3 mmHg (95% CI, 7.7-15.0). No studies reported that cool dialysis led to a reduction in dialysis adequacy as assessed by urea clearance. The frequency and severity of thermal-related symptoms were generally reported inadequately.
Reducing the temperature of the dialysate is an effective intervention to reduce the frequency of IDH and does not adversely affect dialysis adequacy. This applies to the fixed reduction of dialysate temperature and BTM. It remains unclear as to what extent cool-temperature dialysis causes intolerable cold symptoms during dialysis. There are no trials comparing fixed empirical temperature reduction with BTM, and no trials examining the long-term effects of cool dialysis on patient outcomes.
透析中低血压(IDH)是血液透析常见的并发症。降低透析液温度是一种简单的治疗策略,但相对较少使用。这可能是由于担心其对症状和透析充分性的影响。我们对文献进行了系统综述,以研究低温透析对透析中血压的影响,并评估其在热症状和小分子溶质清除方面的安全性。
我们检索了Cochrane对照试验中央注册库、Medline、Embase、护理及相关健康文献累积索引、正在进行的试验数据库、四种主要肾脏杂志的内容以及手工检索参考文献列表。我们纳入了所有前瞻性随机研究,这些研究将任何降低透析液温度的技术与标准碳酸氢盐透析进行了比较。这些技术包括经验性、固定降低透析液温度或使用生物反馈温度控制装置(BTM)进行等温透析或程序化患者降温。
共纳入22项研究,涉及408例患者(16项研究考察了固定经验性温度降低,6项研究考察了BTM)。所有研究均为交叉设计且持续时间相对较短。低温透析(固定降低温度和BTM)时IDH发生频率降低7.1倍(95%CI,5.3 - 8.9)。低温透析后平均动脉压升高11.3 mmHg(95%CI,7.7 - 15.0)。没有研究报告低温透析会导致通过尿素清除评估的透析充分性降低。与热相关症状的频率和严重程度通常报告不足。
降低透析液温度是降低IDH频率的有效干预措施,且不会对透析充分性产生不利影响。这适用于固定降低透析液温度和BTM。目前尚不清楚低温透析在多大程度上会导致透析期间出现无法耐受的寒冷症状。没有试验比较固定经验性温度降低与BTM,也没有试验考察低温透析对患者结局的长期影响。